Table 2.
Correlation between Linc01089 expression and clinicopathological features in NSCLC patients (n=60).
| Characteristics | Number | Linc01089 | P-Value | |
|---|---|---|---|---|
| High expression (n = 18) | Low expression (n = 42) | |||
| Age (year) | 60 | 59.83±7.97 | 58.45±8.61 | 0.5630 |
| Gender (n, %) | 0.5501 | |||
| Female | 40 | 11 (27.50) | 29 (72.50) | |
| Male | 20 | 7 (35.00) | 13 (65.00) | |
| Smoking | 0.6492 | |||
| Y | 26 | 7 (26.92) | 19 (73.08) | |
| N | 34 | 11 (32.35) | 23 (67.65) | |
| TNM stage (n, %) | 0.0355 | |||
| I-II | 44 | 17 (38.64) | 27 (61.36) | |
| III | 16 | 1 (6.25) | 15 (93.75) | |
| Lymph node metastasis (n, %) | 0.0307 | |||
| Y | 26 | 4 (15.38) | 22 (84.62) | |
| N | 34 | 14 (41.18) | 20 (58.82) | |
| Differentiation (n, %) | 0.0044 | |||
| Well moderate | 41 | 17 (41.46) | 24 (58.54) | |
| Poor | 19 | 1 (5.26) | 18 (94.74) | |
| Histologic Type | 0.4519 | |||
| Adenocarcinoma | 47 | 13 (27.66) | 34 (72.34) | |
| Squamous carcinoma | 13 | 5 (38.46) | 8 (61.54) | |